关注
MacLean Pancoast Nasrallah
MacLean Pancoast Nasrallah
在 pennmedicine.upenn.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
DM O’Rourke, MLP Nasrallah, A Desai, JJ Melenhorst, K Mansfield, ...
Science translational medicine 9 (399), eaaa0984, 2017
15382017
A patient-derived glioblastoma organoid model and biobank recapitulates inter-and intra-tumoral heterogeneity
F Jacob, RD Salinas, DY Zhang, PTT Nguyen, JG Schnoll, SZH Wong, ...
Cell 180 (1), 188-204. e22, 2020
6802020
Glioma progression is shaped by genetic evolution and microenvironment interactions
FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ...
Cell 185 (12), 2184-2199. e16, 2022
2102022
Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1
S Rathore, H Akbari, M Rozycki, KG Abdullah, MLP Nasrallah, ZA Binder, ...
Scientific reports 8 (1), 5087, 2018
1682018
Epidermal growth factor receptor extracellular domain mutations in glioblastoma present opportunities for clinical imaging and therapeutic development
ZA Binder, AH Thorne, S Bakas, EP Wileyto, M Bilello, H Akbari, ...
Cancer cell 34 (1), 163-177. e7, 2018
1612018
In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature
H Akbari, S Bakas, JM Pisapia, MLP Nasrallah, M Rozycki, ...
Neuro-oncology 20 (8), 1068-1079, 2018
1082018
Molecular and clinicopathologic features of gliomas harboring NTRK fusions
M Torre, V Vasudevaraja, J Serrano, M DeLorenzo, S Malinowski, ...
Acta Neuropathologica Communications 8, 1-14, 2020
1002020
The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma
R Zeh, S Sheikh, L Xia, J Pierce, A Newton, J Predina, S Cho, ...
PLoS One 12 (7), e0182034, 2017
922017
Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma: a pilot prospective study
SJ Bagley, SA Nabavizadeh, JJ Mays, JE Till, JB Ware, S Levy, ...
Clinical Cancer Research 26 (2), 397-407, 2020
892020
Histopathology‐validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo‐progression in glioblastoma
H Akbari, S Rathore, S Bakas, MLP Nasrallah, G Shukla, E Mamourian, ...
Cancer 126 (11), 2625-2636, 2020
772020
Anti-MOG encephalitis mimicking small vessel CNS vasculitis
K Patterson, E Iglesias, M Nasrallah, V González-Álvarez, M Suñol, ...
Neurology: Neuroimmunology & Neuroinflammation 6 (2), e538, 2019
712019
Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 Tesla
G Verma, S Mohan, MLP Nasrallah, S Brem, JYK Lee, S Chawla, S Wang, ...
Journal of translational medicine 14, 1-8, 2016
532016
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics
S Bakas, C Sako, H Akbari, M Bilello, A Sotiras, G Shukla, JD Rudie, ...
Scientific data 9 (1), 453, 2022
502022
Developmental interneuron subtype deficits after targeted loss of Arx
ED Marsh, MLP Nasrallah, C Walsh, KA Murray, C Nicole Sunnen, ...
BMC neuroscience 17, 1-16, 2016
502016
Differential effects of a polyalanine tract expansion in Arx on neural development and gene expression
MLP Nasrallah, G Cho, JC Simonet, ME Putt, K Kitamura, JA Golden
Human molecular genetics 21 (5), 1090-1098, 2012
472012
Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
I Makhlin, RD Salinas, D Zhang, F Jacob, G Ming, H Song, D Saxena, ...
CNS oncology 8 (3), CNS43, 2019
462019
Case report: prolonged survival following EGFRvIII CAR T cell treatment for recurrent glioblastoma
JS Durgin, F Henderson Jr, MLP Nasrallah, S Mohan, S Wang, SF Lacey, ...
Frontiers in Oncology 11, 669071, 2021
442021
AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium
C Davatzikos, JS Barnholtz-Sloan, S Bakas, R Colen, A Mahajan, ...
Neuro-oncology 22 (6), 886-888, 2020
432020
Three‐dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma
G Verma, S Chawla, S Mohan, S Wang, ML Nasrallah, S Sheriff, A Desai, ...
NMR in Biomedicine 32 (2), e4042, 2019
432019
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors
Y Yin, JL Rodriguez, N Li, R Thokala, MLP Nasrallah, L Hu, L Zhang, ...
Molecular Therapy 30 (7), 2537-2553, 2022
422022
系统目前无法执行此操作,请稍后再试。
文章 1–20